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SENIOR INVESTIGATORS
The Nicotine Addiction Genetics Project
(P.I: Dr. Pamela A.F. Madden)
• Families from the Australian twin registry
• Proband is a heavy smoker (20+ cigarettes/day and also 
includes 40+ cigarettes lifetime)
• Interviewee is affected twin or spouse from discordant pairs of 
ATR or spouse or random twin from concordant pairs
• Affected sibpair + additional affected sibs + both biological 
parents + unaffected sibs with nicotine exposure (fewer than 
100 cigs lifetime)
• Estimated 400 families with current tally of 200 families
Current data (Nfams=196)
• N = 196 families with 1036 individuals
• Average family size = 5
• Founders = 395
• Female = 541
Male = 495
• Mean age = 48 years
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Phenotypic Definitions for Illicit Drugs
• Mjsx : Sum of marijuana dependence symptoms
• Polyuse : Sum of binary use variables (response to “have you   
ever used…”) for marijuana, cocaine, sedatives, 
stimulants, hallucinogens and opiates
• Polydep4 : Sum of binary DSM-IV dependence for 
marijuana, cocaine, sedatives, stimulants,   
hallucinogens and opiates
• Polyabu4 : Sum of binary DSM-IV abuse for 
marijuana, cocaine, sedatives, stimulants,   
hallucinogens and opiates
• log(maxdrink) : maximum drinks in a 24-hr period
All semi-continuous variables were log-transformed, gender, age and age^2 
was regressed out and residuals were used for linkage analyses in 
MERLIN-REGRESS (without ascertainment correction).







Log (maximum alcohol drinks)
Is there an overlap with regions for illicit drugs?
Ref: Saccone, Heath, Madden (unpublished)
Linkage signals for Nicotine-related measures
Are there differences from the illicit drug linkage regions?
Ref: Madden & Heath (unpublished)
Position Phenotype LOD P-value
Chr 2: 84cM FTND 1.81 .002
Chr 7: 117cM Max. Cigs 1.86 .002
Chr 13: 105cM FTND 1.71 .002
Chr 20: 74cM Max. Cigs 1.96 .001
Chr 22: 57cM FTND 2.01 .001
Conclusions
• The signals on chr 3, 4, 6, 8 and 10 seem to 
be unique to illicit drug dependence
• The signals from log(maxdrinks) overlaps 
with the finding from log (maxcigs)
• This signal on chr 7 is well supported by 
other studies (e.g. COGA)
• The signal on chr 6 maps fairly close to the 
cannabinoid receptor gene
• CNR1 located chromosome 6@ 90cM
• G-protein coupled receptor
• CB1 K/O mice exhibit reduced mortality, hypoalgesia but show some 
analgesic effects of THC (Zimmer et al, 1999, PNAS)
• Association study with 154 mood disordered patients and 165 control 
failed to show association between CB1 and psychotic symptoms
• Association study with 127 schizophrenic patients and 146 control failed 
to show association between CB1 and schizophrenia
• No association with alcohol-related phenotypes
• One study suggests that restricting AN and binging/purging AN may be 
associated with different alleles (14 vs 13 rep) of CNR1 
• Long repeats correlated with ADHD in alcoholics in a Spanish sample
Cannabinoid Receptor 1: Chromosome 6
Possible Candidate Gene ?
Work in Progress
• Aim 1: Refine illicit drug use, abuse & dependence 
phenotypes & combine with alcohol/nicotine
• Aim 2: Perform analyses on full sample of 400 
families
• Aim 3: Calculation on empirical p-values from a 
1,000  replicates of the data
• Aim 4: To include other comorbid 
psychopathology, such as conduct disorder, 
personality traits, depression 
